1. A review on the chemotherapeutic potential of fisetin: In vitro evidences
   Kiruthika Sundarraj et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. UNBS5162 inhibits the proliferation of human A549 non-small-cell lung cancer cells by promoting apoptosis
   Cuicui Liu et al, 2017, Thorac Cancer CrossRef
3. Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers
   Sumei Wang et al, 2018, Am. J. Chin. Med. CrossRef
4. Fisetin attenuates isoproterenol-induced cardiac ischemic injury in vivo by suppressing RAGE/NF-κB mediated oxidative stress, apoptosis and inflammation
   Shanky Garg et al, 2018, Phytomedicine CrossRef
5. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy
   Qiu-Lan Zhang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
6. Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma
   Naiyuan Shao et al, 2018, J Neurooncol CrossRef
7. Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells
   Wen LIU et al, 2018, Chinese Journal of Natural Medicines CrossRef
8. Carnosic acid exhibits antiproliferative and proapoptotic effects in tumoral NCI-H460 and nontumoral IMR-90 lung cells
   Amanda Cristina Corveloni et al, 2020, Journal of Toxicology and Environmental Health, Part A CrossRef
9. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS
   Hong-Mao Song et al, 2018, Int J Mol Med CrossRef
10. Fisetin: An anticancer perspective
    Muhammad Imran et al, 2020, Food Sci Nutr CrossRef
11. Natural products: potential treatments for cisplatin-induced nephrotoxicity
    Chun-yan Fang et al, 2021, Acta Pharmacol Sin CrossRef
12. Cancer chemopreventive role of fisetin: Regulation of cell signaling pathways in different cancers
    Ammad Ahmad Farooqi et al, 2021, Pharmacological Research CrossRef
13. Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
    Peter Kubatka et al, 2021, EPMA Journal CrossRef
14. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells
    Lu Han et al, 2022, Molecular and Cellular Probes CrossRef
15. Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation
    Junjun Ling et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
16. Advances on Natural Abietane, Labdane and Clerodane Diterpenes as Anti-Cancer Agents: Sources and Mechanisms of Action
    Rosaria Acquaviva et al, 2022, Molecules CrossRef
17. Effects of rosmarinic acid, carnosic acid, rosmanol, carnosol, and ursolic acid on the pathogenesis of respiratory diseases
    Faegheh Farhadi et al, 2022, BioFactors CrossRef
18. Cancer combination therapy with carnosic acid
    NADIRE 諾ENVER et al, 2022 CrossRef
19. Cancer Protective Role of Selected Dietary Polyphenols via Modulating Keap1/Nrf2/ARE and Interconnected Signaling Pathways
    Md Arman Islam et al, 2023, Nutrition and Cancer CrossRef
20. Natural Flavonoids in the Prevention and Treatment of Lung Cancer: A Pharmacological Aspect
    Rajat Nath et al, 2023, CCHTS CrossRef
21. null
    Jan O. Nehlin, 2023 CrossRef
22. Naringenin in combination with quercetin/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines
    Masoume Jalalpour Choupanan et al, 2023, Mol Biol Rep CrossRef
23. null
    Simon Vlad Luca et al, 2023 CrossRef
24. Exploring the Potential of Rosemary Derived Compounds (Rosmarinic and Carnosic Acids) as Cancer Therapeutics: Current Knowledge and Future Perspectives
    Fazila Sirajudeen et al, 2024, Biomol Ther (Seoul) CrossRef